Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

PYXS

Pyxis Oncology, Inc.

Tremor tracks 1 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

  • PYXSPyxis Oncology, Inc
    0Calm

    Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

    Signing up patientsPhase 1/2220 patientsMain results: Dec 6, 2027

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

1 sale (0 not pre-planned) · 1 purchase

  • GordonMD Global Investments LPLarge shareholder · Oct 1, 2026Bought 5,517,000 shares
  • Dupont JakobBoard member · Jun 30, 2026Sold 35,000 sharesabout $107 thousand · pre-planned

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • Quarterly reportQuarterly report (10-Q)Nov 5, 2026
  • Shared quarterly resultsNews report (8-K)Nov 5, 2026
  • Signed a major agreement; Other newsNews report (8-K)Oct 1, 2026
  • New shares being soldNew shares being sold (424B5)Oct 1, 2026
  • New shares being soldNew shares being sold (424B5)Sep 29, 2026

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.
New shares being soldNew shares being sold (424B5)
Sep 29, 2026
  • Shared information with investors; Other newsNews report (8-K)Sep 9, 2026
  • An executive or board member joined or left; Shared information with investorsNews report (8-K)Sep 8, 2026
  • Permission to sell new sharesPermission to sell new shares (S-3)Aug 20, 2026
  • Quarterly reportQuarterly report (10-Q)Aug 13, 2026
  • Shared quarterly resultsNews report (8-K)Aug 13, 2026
  • Signed a major agreement; Shared information with investorsNews report (8-K)Jul 2, 2026
  • News reportNews report (8-K)Jun 15, 2026
  • Quarterly reportQuarterly report (10-Q)May 14, 2026
  • Shared quarterly resultsNews report (8-K)May 14, 2026